Welcome to the ACT Member Network

Last Call: ACT’s Free Educational Webinar on December 19

 

You are Invited to Participate in a Free Educational Webinar

Safety Assessment of Monoclonal Antibodies for Immunosuppressants and Anti-Inflammatory Agents

Wednesday, December 19, 2018

Time: 11:00 AM ET

Hosted by the American College of Toxicology

In Collaboration with the British Toxicology Society and the Society of Toxicologic Pathology

Speakers:

Simone Nicholson, PhD, DABT
Senior Toxicologist, Biologics Safety Assessment, MedImmune LLC

Talk 1: Introduction: Biologics for the Treatment of Immune-Mediated Inflammatory Disease

Hervé Lebrec, PharmD, PhD, DABT
Scientific Director, Nonclinical Safety Sciences, Amgen Inc.

Talk 2: Immune Safety Assessments for Immunosuppressive Agents: Tools and Applications

Shawn Heidel, DVM, PhD
Vice President and Head, Global Safety Assessment, Covance Laboratories, Inc.

Talk 3: Carcinogenicity Assessment of Biologics

Ken Hastings, DrPH, DABT, ATS
Hastings Toxicology Consulting, LLC

Talk 4: Regulatory Aspects and Interpretation of Immunosuppression AE in Nonclinical Studies

There is no fee but advance registration is required.

View Abstract

ACT Educational Webinar

Recent Stories
Last Call: ACT's 2019 Annual Meeting Session Proposals

Last Call: ACT’s Free Educational Webinar on December 19

Registration Open for ACT's Free Educational Webinar on December 19